Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Population | 1 | 2019 | 114 | 0.77 | Why? |
| Homosexuality, Male | 5 | 2019 | 1158 | 0.67 | Why? |
| HIV Infections | 14 | 2021 | 11620 | 0.65 | Why? |
| Gender-Based Violence | 1 | 2018 | 107 | 0.64 | Why? |
| Sexual Behavior | 4 | 2018 | 1322 | 0.59 | Why? |
| Pre-Exposure Prophylaxis | 3 | 2018 | 1138 | 0.55 | Why? |
| Acquired Immunodeficiency Syndrome | 2 | 2019 | 533 | 0.52 | Why? |
| Syphilis | 1 | 2017 | 318 | 0.50 | Why? |
| Surge Capacity | 1 | 2020 | 894 | 0.48 | Why? |
| Sex Workers | 5 | 2021 | 348 | 0.45 | Why? |
| Canada | 7 | 2021 | 6018 | 0.44 | Why? |
| Epidemics | 3 | 2021 | 6407 | 0.42 | Why? |
| Anti-HIV Agents | 3 | 2019 | 2209 | 0.41 | Why? |
| Cost of Illness | 1 | 2021 | 1903 | 0.40 | Why? |
| Cost-Benefit Analysis | 2 | 2018 | 2259 | 0.37 | Why? |
| Sexual Partners | 3 | 2019 | 612 | 0.28 | Why? |
| Mass Screening | 3 | 2019 | 8005 | 0.25 | Why? |
| Hemorrhagic Fever, Ebola | 3 | 2019 | 1475 | 0.24 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.24 | Why? |
| Ontario | 4 | 2021 | 1966 | 0.23 | Why? |
| Models, Theoretical | 5 | 2020 | 6659 | 0.23 | Why? |
| Kenya | 3 | 2019 | 887 | 0.23 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.21 | Why? |
| Genetic Heterogeneity | 1 | 2020 | 77 | 0.21 | Why? |
| Violence | 2 | 2017 | 534 | 0.19 | Why? |
| Homeless Persons | 2 | 2020 | 1171 | 0.19 | Why? |
| Epidemiologic Studies | 1 | 2021 | 554 | 0.18 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.17 | Why? |
| Bisexuality | 1 | 2018 | 119 | 0.17 | Why? |
| Travel | 3 | 2020 | 7220 | 0.16 | Why? |
| Practice Patterns, Nurses' | 1 | 2019 | 140 | 0.16 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.15 | Why? |
| Occupations | 1 | 2021 | 733 | 0.15 | Why? |
| Transitional Care | 1 | 2017 | 135 | 0.14 | Why? |
| Geography | 1 | 2021 | 1801 | 0.14 | Why? |
| Cataract Extraction | 1 | 2018 | 201 | 0.14 | Why? |
| Ebolavirus | 2 | 2019 | 834 | 0.14 | Why? |
| Body Fluids | 1 | 2018 | 451 | 0.13 | Why? |
| Eye | 1 | 2018 | 374 | 0.13 | Why? |
| Family Conflict | 1 | 2013 | 50 | 0.13 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.13 | Why? |
| Sex Work | 1 | 2013 | 96 | 0.13 | Why? |
| Primary Prevention | 1 | 2020 | 778 | 0.12 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.12 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.12 | Why? |
| Human Rights | 1 | 2020 | 618 | 0.12 | Why? |
| Spatial Analysis | 1 | 2018 | 878 | 0.12 | Why? |
| Decision Support Systems, Clinical | 1 | 2017 | 551 | 0.12 | Why? |
| Social Class | 1 | 2020 | 1360 | 0.11 | Why? |
| Public Health Practice | 1 | 2020 | 945 | 0.11 | Why? |
| Public Health Administration | 1 | 2020 | 846 | 0.11 | Why? |
| Women | 1 | 2013 | 159 | 0.11 | Why? |
| Morals | 1 | 2017 | 483 | 0.11 | Why? |
| Humans | 30 | 2021 | 930598 | 0.11 | Why? |
| Self Care | 1 | 2019 | 918 | 0.11 | Why? |
| Sexual and Gender Minorities | 2 | 2018 | 1019 | 0.11 | Why? |
| Nurse's Role | 1 | 2019 | 614 | 0.11 | Why? |
| Clinical Protocols | 2 | 2019 | 2734 | 0.10 | Why? |
| Community Health Services | 1 | 2019 | 1000 | 0.10 | Why? |
| Residence Characteristics | 1 | 2021 | 1927 | 0.10 | Why? |
| Safe Sex | 2 | 2021 | 135 | 0.10 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.10 | Why? |
| Anti-Retroviral Agents | 1 | 2018 | 1099 | 0.10 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.10 | Why? |
| Social Determinants of Health | 1 | 2021 | 1757 | 0.09 | Why? |
| Continuity of Patient Care | 1 | 2019 | 1574 | 0.09 | Why? |
| Condoms | 2 | 2021 | 235 | 0.09 | Why? |
| Long-Term Care | 1 | 2020 | 2047 | 0.09 | Why? |
| Prisoners | 1 | 2017 | 738 | 0.09 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.09 | Why? |
| Sierra Leone | 2 | 2018 | 267 | 0.08 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.08 | Why? |
| HIV-1 | 1 | 2021 | 3365 | 0.08 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.08 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.07 | Why? |
| Communicable Diseases | 1 | 2020 | 2148 | 0.07 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Schools | 1 | 2021 | 4187 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.07 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.06 | Why? |
| Health Policy | 2 | 2020 | 6242 | 0.06 | Why? |
| Adult | 13 | 2021 | 244371 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.06 | Why? |
| Benin | 1 | 2021 | 115 | 0.06 | Why? |
| Poverty | 1 | 2013 | 2302 | 0.06 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.06 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.05 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.05 | Why? |
| Male | 10 | 2021 | 367725 | 0.05 | Why? |
| Female | 10 | 2021 | 380317 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
| Cameroon | 1 | 2021 | 464 | 0.05 | Why? |
| Amodiaquine | 1 | 2019 | 57 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Sexually Transmitted Diseases | 2 | 2018 | 694 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 13720 | 0.04 | Why? |
| Environmental Health | 1 | 2020 | 203 | 0.04 | Why? |
| Secondary Care Centers | 1 | 2017 | 119 | 0.04 | Why? |
| Artemisinins | 1 | 2019 | 238 | 0.04 | Why? |
| School Teachers | 1 | 2021 | 345 | 0.04 | Why? |
| Surveys and Questionnaires | 3 | 2018 | 43792 | 0.04 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.04 | Why? |
| Selection Bias | 1 | 2017 | 201 | 0.04 | Why? |
| Qualitative Research | 2 | 2019 | 4337 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2019 | 9044 | 0.04 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Cataract | 1 | 2018 | 186 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Focus Groups | 1 | 2018 | 811 | 0.03 | Why? |
| Human Trafficking | 1 | 2013 | 9 | 0.03 | Why? |
| Gonorrhea | 1 | 2018 | 315 | 0.03 | Why? |
| Risk-Taking | 1 | 2018 | 508 | 0.03 | Why? |
| Models, Biological | 2 | 2021 | 4907 | 0.03 | Why? |
| Coercion | 1 | 2013 | 57 | 0.03 | Why? |
| Sweden | 1 | 2020 | 1969 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Sexual Health | 1 | 2018 | 419 | 0.03 | Why? |
| Research Design | 2 | 2019 | 5830 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.03 | Why? |
| Visual Acuity | 1 | 2018 | 790 | 0.03 | Why? |
| Social Networking | 1 | 2018 | 737 | 0.03 | Why? |
| Aged | 4 | 2020 | 215776 | 0.03 | Why? |
| Family Practice | 1 | 2018 | 472 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Program Evaluation | 1 | 2019 | 1929 | 0.03 | Why? |
| Urban Population | 1 | 2021 | 2000 | 0.03 | Why? |
| Public Health | 3 | 2020 | 16359 | 0.03 | Why? |
| Drug Combinations | 1 | 2019 | 3852 | 0.02 | Why? |
| South Africa | 1 | 2019 | 3326 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Workplace | 1 | 2021 | 2075 | 0.02 | Why? |
| Pyrazines | 1 | 2019 | 1783 | 0.02 | Why? |
| Amides | 1 | 2019 | 1864 | 0.02 | Why? |
| India | 2 | 2017 | 11875 | 0.02 | Why? |
| Interviews as Topic | 1 | 2017 | 1952 | 0.02 | Why? |
| Ambulatory Care Facilities | 1 | 2018 | 2063 | 0.02 | Why? |
| Antiviral Agents | 1 | 2019 | 41703 | 0.02 | Why? |
| Computer Simulation | 1 | 2021 | 4982 | 0.02 | Why? |
| Universities | 1 | 2021 | 4374 | 0.02 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2019 | 9893 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.02 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.02 | Why? |
| Students | 1 | 2021 | 5255 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2019 | 8041 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
Mishra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(162)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(112)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_